Benitec Biopharma BNTC $0.24 B$10.480.77%🇺🇸USA 115 Sangamo Therapeutics SGMO $0.23 B$1.140.00%🇺🇸USA 316 Voyager Therapeutics VYGR $0.23 B$4.220.36%🇺🇸USA 17 Editas Medicine EDIT $96.16 M$1.161.27%🇺🇸USA
(2009). No M&A deal from the 2020s made it into the top list so far. The most recent big deals were the acquisitions of Allergan by AbbVie and of Celgene by Bristol-Myers Squibb, both in 2019. In 2023, the largest biopharma M&A deal was the acquisition of Seagen by Pfizer, valued ...